Fabino Enterprises Limited

₹20.31As of Sun 8 Nov 2026, 12:00 UTC
BSE:543444Healthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR (11.15%)
Div yield —
ROE (14.23%)
Pharmaceutical Preparations
Beta (5Y) (0.14)
PE TTM —
TSR TTM (11.70%)
Mkt cap ₹42.65M
ROIC (28.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹22
10.57%
535.08%
Hold 9|7|8|9|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.41
0.44
0.47
0.46
14.05%
10.03%
21.78%
12.23%
Revenue₹M
5.395
5.708
5.611
5.903
2.27%
10.30%
7.62%
9.75%
Peers (US$0.454M)
Cap (US$)
PE
0.630M
213.3x
Capital
TTM
5Y
10Y
Leveragex
0.752
1.197
0.900
EBIT/Intx
1.932
0.616
0.512
Own earn%
3.76
3.42
(2.02)
Sh yield%
21.86
33.98
35.87
Owners
Insiders/Inst%
12.85
38.30
Short interest%
1.47
SBC / revenue%
5.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–22
$1 testx
0.0
Incr. ROIC%
2